Literature DB >> 29706454

A-to-I RNA Editing Contributes to Proteomic Diversity in Cancer.

Xinxin Peng1, Xiaoyan Xu2, Yumeng Wang3, David H Hawke4, Shuangxing Yu5, Leng Han6, Zhicheng Zhou7, Kamalika Mojumdar1, Kang Jin Jeong5, Marilyne Labrie5, Yiu Huen Tsang8, Minying Zhang9, Yiling Lu5, Patrick Hwu10, Kenneth L Scott8, Han Liang11, Gordon B Mills5.   

Abstract

Adenosine (A) to inosine (I) RNA editing introduces many nucleotide changes in cancer transcriptomes. However, due to the complexity of post-transcriptional regulation, the contribution of RNA editing to proteomic diversity in human cancers remains unclear. Here, we performed an integrated analysis of TCGA genomic data and CPTAC proteomic data. Despite limited site diversity, we demonstrate that A-to-I RNA editing contributes to proteomic diversity in breast cancer through changes in amino acid sequences. We validate the presence of editing events at both RNA and protein levels. The edited COPA protein increases proliferation, migration, and invasion of cancer cells in vitro. Our study suggests an important contribution of A-to-I RNA editing to protein diversity in cancer and highlights its translational potential.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ADAR enzyme; CPTAC; RNA editing; RNA-seq; TCGA; amino acid changes; biomarker; cancer drivers; mass spectrometry data; somatic mutations

Mesh:

Substances:

Year:  2018        PMID: 29706454      PMCID: PMC5953833          DOI: 10.1016/j.ccell.2018.03.026

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  46 in total

Review 1.  From birth to death: the complex lives of eukaryotic mRNAs.

Authors:  Melissa J Moore
Journal:  Science       Date:  2005-09-02       Impact factor: 47.728

2.  PeptideShaker enables reanalysis of MS-derived proteomics data sets.

Authors:  Marc Vaudel; Julia M Burkhart; René P Zahedi; Eystein Oveland; Frode S Berven; Albert Sickmann; Lennart Martens; Harald Barsnes
Journal:  Nat Biotechnol       Date:  2015-01       Impact factor: 54.908

3.  Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma.

Authors:  Leilei Chen; Yan Li; Chi Ho Lin; Tim Hon Man Chan; Raymond Kwok Kei Chow; Yangyang Song; Ming Liu; Yun-Fei Yuan; Li Fu; Kar Lok Kong; Lihua Qi; Yan Li; Na Zhang; Amy Hin Yan Tong; Dora Lai-Wan Kwong; Kwan Man; Chung Mau Lo; Si Lok; Daniel G Tenen; Xin-Yuan Guan
Journal:  Nat Med       Date:  2013-01-06       Impact factor: 53.440

4.  Proteogenomic characterization of human colon and rectal cancer.

Authors:  Bing Zhang; Jing Wang; Xiaojing Wang; Jing Zhu; Qi Liu; Zhiao Shi; Matthew C Chambers; Lisa J Zimmerman; Kent F Shaddox; Sangtae Kim; Sherri R Davies; Sean Wang; Pei Wang; Christopher R Kinsinger; Robert C Rivers; Henry Rodriguez; R Reid Townsend; Matthew J C Ellis; Steven A Carr; David L Tabb; Robert J Coffey; Robbert J C Slebos; Daniel C Liebler
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

5.  Genome engineering using the CRISPR-Cas9 system.

Authors:  F Ann Ran; Patrick D Hsu; Jason Wright; Vineeta Agarwala; David A Scott; Feng Zhang
Journal:  Nat Protoc       Date:  2013-10-24       Impact factor: 13.491

6.  ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.

Authors:  Tim Hon Man Chan; Aditi Qamra; Kar Tong Tan; Jing Guo; Henry Yang; Lihua Qi; Jaymie Siqi Lin; Vanessa Hui En Ng; Yangyang Song; Huiqi Hong; Su Ting Tay; Yujing Liu; Jeeyun Lee; Sun Yong Rha; Feng Zhu; Jimmy Bok Yan So; Bin Tean Teh; Khay Guan Yeoh; Steve Rozen; Daniel G Tenen; Patrick Tan; Leilei Chen
Journal:  Gastroenterology       Date:  2016-07-01       Impact factor: 22.682

7.  Role of conformational sampling in computing mutation-induced changes in protein structure and stability.

Authors:  Elizabeth H Kellogg; Andrew Leaver-Fay; David Baker
Journal:  Proteins       Date:  2010-12-03

8.  i-Tracker: for quantitative proteomics using iTRAQ.

Authors:  Ian P Shadforth; Tom P J Dunkley; Kathryn S Lilley; Conrad Bessant
Journal:  BMC Genomics       Date:  2005-10-20       Impact factor: 3.969

9.  I-TASSER server for protein 3D structure prediction.

Authors:  Yang Zhang
Journal:  BMC Bioinformatics       Date:  2008-01-23       Impact factor: 3.169

10.  TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions.

Authors:  Daehwan Kim; Geo Pertea; Cole Trapnell; Harold Pimentel; Ryan Kelley; Steven L Salzberg
Journal:  Genome Biol       Date:  2013-04-25       Impact factor: 13.583

View more
  68 in total

Review 1.  Adenosine deaminase acting on RNA (ADAR1), a suppressor of double-stranded RNA-triggered innate immune responses.

Authors:  Charles E Samuel
Journal:  J Biol Chem       Date:  2019-02-01       Impact factor: 5.157

Review 2.  Single-nucleotide variants in human RNA: RNA editing and beyond.

Authors:  Yan Guo; Hui Yu; David C Samuels; Wei Yue; Scott Ness; Ying-Yong Zhao
Journal:  Brief Funct Genomics       Date:  2019-02-14       Impact factor: 4.241

Review 3.  A molecular-level perspective on the frequency, distribution, and consequences of messenger RNA modifications.

Authors:  Joshua D Jones; Jeremy Monroe; Kristin S Koutmou
Journal:  Wiley Interdiscip Rev RNA       Date:  2020-01-21       Impact factor: 9.957

4.  A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis.

Authors:  Xiaoyan Xu; Yumeng Wang; Kamalika Mojumdar; Zhicheng Zhou; Kang Jin Jeong; Lingegowda S Mangala; Shuangxing Yu; Yiu Huen Tsang; Cristian Rodriguez-Aguayo; Yiling Lu; Gabriel Lopez-Berestein; Anil K Sood; Gordon B Mills; Han Liang
Journal:  J Clin Invest       Date:  2019-12-02       Impact factor: 14.808

5.  Hyper-Editing of Cell-Cycle Regulatory and Tumor Suppressor RNA Promotes Malignant Progenitor Propagation.

Authors:  Qingfei Jiang; Jane Isquith; Maria Anna Zipeto; Raymond H Diep; Jessica Pham; Nathan Delos Santos; Eduardo Reynoso; Julisia Chau; Heather Leu; Elisa Lazzari; Etienne Melese; Wenxue Ma; Rongxin Fang; Mark Minden; Sheldon Morris; Bing Ren; Gabriel Pineda; Frida Holm; Catriona Jamieson
Journal:  Cancer Cell       Date:  2019-01-03       Impact factor: 31.743

Review 6.  Proteomics advances for precision therapy in ovarian cancer.

Authors:  Marilyne Labrie; Nicholas D Kendsersky; Hongli Ma; Lydia Campbell; Jennifer Eng; Koei Chin; Gordon B Mills
Journal:  Expert Rev Proteomics       Date:  2019-09-13       Impact factor: 3.940

Review 7.  Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer.

Authors:  Shakur Mohibi; Xinbin Chen; Jin Zhang
Journal:  Pharmacol Ther       Date:  2019-07-11       Impact factor: 12.310

Review 8.  RNA Dysregulation: An Expanding Source of Cancer Immunotherapy Targets.

Authors:  Yang Pan; Kathryn E Kadash-Edmondson; Robert Wang; John Phillips; Song Liu; Antoni Ribas; Richard Aplenc; Owen N Witte; Yi Xing
Journal:  Trends Pharmacol Sci       Date:  2021-04       Impact factor: 14.819

9.  Inflammation-driven deaminase deregulation fuels human pre-leukemia stem cell evolution.

Authors:  Qingfei Jiang; Jane Isquith; Luisa Ladel; Adam Mark; Frida Holm; Cayla Mason; Yudou He; Phoebe Mondala; Isabelle Oliver; Jessica Pham; Wenxue Ma; Eduardo Reynoso; Shawn Ali; Isabella Jamieson Morris; Raymond Diep; Chanond Nasamran; Guorong Xu; Roman Sasik; Sara Brin Rosenthal; Amanda Birmingham; Sanja Coso; Gabriel Pineda; Leslie Crews; Mary E Donohoe; J Craig Venter; Thomas Whisenant; Ruben A Mesa; Ludmil B Alexandrov; Kathleen M Fisch; Catriona Jamieson
Journal:  Cell Rep       Date:  2021-01-26       Impact factor: 9.423

Review 10.  To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis.

Authors:  Emily A Erdmann; Ananya Mahapatra; Priyanka Mukherjee; Boyoon Yang; Heather A Hundley
Journal:  Crit Rev Biochem Mol Biol       Date:  2020-12-27       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.